Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046476Phase 4Recruiting
Phase 4 trial of remimazolam (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Successful sedation rate and Hypotension rate. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046476.